dr reddy's glp-1 drugs portfolio 2025 Dr. Laboratories has entered the fast-growing therapy segment with the launch of its semaglutide generic, Obeda, for Type 2 diabetes in India's ₹1,446 crore market. 𝐑𝐞𝐚𝐝 𝐟𝐮𝐥𝐥 𝐚𝐫𝐭𝐢𝐜𝐥𝐞 𝐨𝐧 𝐨𝐮𝐫 Dr. Reddy's gets approval for

PT-141 (bremelanotide) is a synthetic peptide, but what makes it stand out is how it works

Organosulfur derivatives of alliin in the process of garlic product preparation The figure illustrates the organosulfur derivatives formed from S-allyl-L-cysteine sulfoxide (alliin) during garlic processing

doi: 10.3390/ijms22020544 40 LiuSWuZChenXChenZShenYQadirSet al

It primarily cleaves peptides at the N-terminal side of aromatic or hydrophobic amino acids and is estimated to contribute by up to 50% to GLP-1 degradation

Surman CBH, Walsh DM

A healthy liver is essential for efficient fat metabolism, making this amino acid a key contributor